Drug intelligence / Profile preview

3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a small molecule belonging to the class of medium-chain keto acids and derivatives. It has a molecular formula of C12H8F2O4 and is not approved by the FDA or EMA. There is no specific indication or clinical trial information available for this compound. It is involved in interactions with enzymes like BphD, which is part of the biphenyl catabolic pathway, but its role as a drug is not well-defined.

Other names: (2Z,4E)-3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acidAcide (2Z,4E)-3-fluoro-6-(4-fluorophényl)-2-hydroxy-6-oxo-2,4-hexadiénoïque

Beyond the preview

Go deeper on 3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid.

Explore the full profile